Skip to content

Clinical trials

Dyslipidemias trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Country / region: South Korea Clear all

135 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20074
20081
20114
20121
20132
20146
20159
201610
20179
20188
201913
20206
202114
202213
202310
20248
20258
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed88
Unknown status19
Recruiting17
Active, not recruiting9
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chong Kun Dang Pharmaceutical37
Yonsei University12
Daewoong Pharmaceutical Co. LTD.11
JW Pharmaceutical6
Seoul National University Hospital5
Yuhan Corporation5
AstraZeneca4
Boryung Pharmaceutical Co., Ltd4
Hanmi Pharmaceutical Company Limited4
Yooyoung Pharmaceutical Co., Ltd.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias135
Hypertension51
Diabetes Mellitus, Type 213
Hypercholesterolemia11
Diabetes Mellitus8
Atherosclerosis7
Cardiovascular Diseases4
Coronary Artery Disease4
Essential Hypertension3
Metabolic Syndrome3

Trials

Showing 1 to 25 of 135. Each trial links to its page on Pharma Observatory.

35 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.